In what situations would you offer salvage radiotherapy for relapsed/refractory DLBCL?

Topics: Hematologic Malignancies • Radiation Oncology • Hematology

NCCN only recommends palliative ISRT for non-transplant eligible patients with refractory/relapsed DLBCL

Answer from: Radiation Oncologist at Academic Institution

There are a number of different clinical scenarios when I would consider RT in patients with relapsed/refractory DLBCL. NCCN guidelines (page BCEL-7 and BCEL-8) list RT as an option in several of these settings.1. Relapsed disease s/p autologous or allogeneic stem cell transplantation - In patients ...

Comments

Radiation Oncologist at Duke University Medical Center
To this list, I would add patients who present wit...

Related Questions